Видео ютуба по тегу Event: Esmo Breast 2023

Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO Florida
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO Florida
How to Make Sense of Breast Cancer Data from ESMO 2025
How to Make Sense of Breast Cancer Data from ESMO 2025
Breast cancer at ESMO 2023: ADCs and MONARCH 3
Breast cancer at ESMO 2023: ADCs and MONARCH 3
Refining Classification and Staging in Breast Cancer – Biology Matters Alot: 2022 ESMO Florida
Refining Classification and Staging in Breast Cancer – Biology Matters Alot: 2022 ESMO Florida
【Teaser Trailer】Highlights on ESMO 2023 BREAST CANCER & Opinions of EurAsia oncology center experts
【Teaser Trailer】Highlights on ESMO 2023 BREAST CANCER & Opinions of EurAsia oncology center experts
ESMO 2023: Key messages for breast cancer treatment
ESMO 2023: Key messages for breast cancer treatment
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2023
UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2023
Key lectures from ESMO Breast Cancer 2022
Key lectures from ESMO Breast Cancer 2022
2023 What Changes Monday Morning? | ESMO Breast Cancer Webinar
2023 What Changes Monday Morning? | ESMO Breast Cancer Webinar
“Moving the needle” in the metastatic breast cancer setting: 2022 ESMO Florida
“Moving the needle” in the metastatic breast cancer setting: 2022 ESMO Florida
Genomic classifiers in breast cancer: Prognostic and predictive information: 2022 ESMO Florida
Genomic classifiers in breast cancer: Prognostic and predictive information: 2022 ESMO Florida
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium
Breast cancer highlights from ESMO 2025
Breast cancer highlights from ESMO 2025
Highlights from ESMO 2025
Highlights from ESMO 2025
Critical Review of ESMO 2025 in Breast Cancer Treatment Approach
Critical Review of ESMO 2025 in Breast Cancer Treatment Approach